Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02096718
What this trial is testing

Afatinib in Subjects With Kidney Dysfunction

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 30
Early research (Phase 1)Study completedNCT03506854
What this trial is testing

Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients

Who this might be right for
Renal Impairment
Akcea Therapeutics 16
Early research (Phase 1)Study completedNCT04935294
What this trial is testing

Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction

Who this might be right for
HealthyRenal Dysfunction
Alexion Pharmaceuticals, Inc. 16
Early research (Phase 1)Study completedNCT03186495
What this trial is testing

Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function

Who this might be right for
Growth Hormone DisorderAdult Growth Hormone DeficiencyGrowth Hormone Deficiency in Children
Novo Nordisk A/S 44
Early research (Phase 1)Study completedNCT01833754
What this trial is testing

Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis

Who this might be right for
Osteoporosis
Amgen 24
Early research (Phase 1)Study completedNCT01575925
What this trial is testing

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)

Who this might be right for
Multiple MyelomaRenal Impairment
Celgene 25
Early research (Phase 1)Study completedNCT03235076
What this trial is testing

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal Impairment
Bayer 36
Testing effectiveness (Phase 2)Study completedNCT00527215
What this trial is testing

Phase 2 Study of Darbepoetin Alfa Extended Dosing

Who this might be right for
Pre-Dialysis
Amgen 98
Early research (Phase 1)Study completedNCT02340195
What this trial is testing

Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function

Who this might be right for
Alzheimer Disease
H. Lundbeck A/S 16
Large-scale testing (Phase 3)Study completedNCT00436995
What this trial is testing

Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis

Who this might be right for
Chronic Kidney Disease
Amgen 114
Early research (Phase 1)Study completedNCT01464931
What this trial is testing

Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis

Who this might be right for
Renal Impairment
Amgen 32
Early research (Phase 1)Study completedNCT00543075
What this trial is testing

Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function

Who this might be right for
Normal Renal FunctionMildly Impaired Renal FunctionModerately Impaired Renal Function
Genta Incorporated 23
Early research (Phase 1)Study completedNCT02191228
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 51
Large-scale testing (Phase 3)Study completedNCT03543657
What this trial is testing

Maintenance Treatment of Renal Anemia in Dialysis Subjects

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 229
Early research (Phase 1)Study completedNCT00445302
What this trial is testing

Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Genzyme, a Sanofi Company 23
Early research (Phase 1)Study completedNCT00888069
What this trial is testing

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT00721734
What this trial is testing

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Who this might be right for
Multiple MyelomaRenal Insufficiency
Amgen 50
Post-approval studies (Phase 4)WithdrawnNCT00328809
What this trial is testing

Spironolactone Safety in Dialysis Patients

Who this might be right for
End Stage Renal DiseaseCongestive Heart Failure
State University of New York - Upstate Medical University
Testing effectiveness (Phase 2)Ended earlyNCT02075463
What this trial is testing

Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia

Who this might be right for
AnemiaAnaemia
GlaxoSmithKline 15
Large-scale testing (Phase 3)Study completedNCT00702715
What this trial is testing

Comparison of 4.0 mg/kg Sugammadex at 1-2 Post Tetanic Counts (PTC) in Renal or Control Patients (19.4.328)(P05769)

Who this might be right for
Anesthesia
Merck Sharp & Dohme LLC 69
Next Page